AJP - Renal Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol 260: F688-F694, 1991;
0363-6127/91 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kapoor, S. C.
Right arrow Articles by Krishna, G. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kapoor, S. C.
Right arrow Articles by Krishna, G. G.

AJP - Renal Physiology, Vol 260, Issue 5 688-F694, Copyright © 1991 by American Physiological Society


ARTICLES

Protein-induced modulation of renin secretion is mediated by prostaglandins

S. C. Kapoor and G. G. Krishna
Department of Medicine, Temple University School of Medicine, Philadelphia, Pennsylvania 19140.

Dietary protein restriction inhibits glomerular prostaglandin (PG) synthesis and lowers plasma renin activity (PRA). To investigate the role of PG in mediating protein-induced alterations in renin secretion, male Sprague-Dawley rats were fed isocaloric diets providing either a standard 20% protein or a low-protein (6%) diet for 3 wk. An additional group of rats received a PG synthesis inhibitor, meclofenamate (25 mg/l), in the drinking water along with the 20% protein diet. Both protein restriction and meclofenamate administration significantly (P less than 0.025) lowered glomerular PGE2 production. Compared with standard protein intake, low protein intake lowered basal PRA (3.96 +/- 0.16 vs. 1.58 +/- 0.12 ng.ml-1.h-1, P less than 0.001), stimulated PRA (11.6 +/- 2.3 vs. 5.5 +/- 0.7 ng.ml-1.h-1, P less than 0.025), renal venous PRA (10.0 +/- 0.7 vs. 7.02 +/- 0.72 ng.ml-1.h-1, P less than 0.02), and plasma angiotensin II (ANG II) levels (52 +/- 5 vs. 24 +/- 3 pg/ml, P less than 0.01), while augmenting renal tissue renin content (2.36 +/- 0.21 vs. 3.56 +/- 0.30 micrograms/mg protein, P less than 0.005). Changes in plasma and renal tissue renin on meclofenamate treatment were similar to those observed on 6% protein diet. Both protein restriction and meclofenamate administration increased the glomerular ANG II receptor number, while the receptor affinity was unchanged. Thus protein restriction lowers PRA by impairing release of renin into circulation. This impairment in renin release is mediated by PG.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online